Vaxcyte Announces Closing of $862.5 Million Public Offering

SAN CARLOS, Calif., Feb. 02, 2024 -- Vaxcyte, Inc. , a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases,...

Related Keywords

Charlotte , North Carolina , United States , New York , Boston , Massachusetts , Jennifer Zibuda , Janet Graesser , Corporate Communications , Groupa Strep , Needham Company , Leerink Partners , Exchange Commission , Vaxcyte Inc , Syndicate Department , Equity Syndicate Department , Nasdaq , Evercore Group , Globenewswire Inc , Prospectus Department , Sutro Biopharma Inc , Tryon Street , Capital Markets , Sutro Biopharma , Vice President , Senior Director , Markets ,